Women employed at Novo Nordisk A/S are now paid more on average than the men working at the maker of blockbuster drugs Wegovy ...

No drug is without potential side effects, and there are five major ones that people taking Ozempic, Wegovy or Mounjaro are ...

BBB National Programs’ National Advertising Division reviewed a challenge brought by Novo Nordisk Inc. regarding express and ...

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

As consumers taking medications like Ozempic cut back on eating out, about 70% are spending more on cooking at home, ...

WOMEN on fat jabs must take effective contraception, health chiefs have warned for the first time. It comes amid claims of an ‘Ozempic baby boom’ – with more women becoming pregnant while ...

Eli Lilly, the global pharmaceutical giant, said the Therapeutic Goods Administration had approved the use of its Mounjaro ...

That’s up from a rate of 9.9 prescriptions per 100,000 in 2023, the first full year that Wegovy was available to children ...

Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...

The deal, which could be worth up to $870 million overall, will give Lilly access to a delivery technology that may help extend the durability of up to four of its weight-loss medicines.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

For the second night in a row, Elon Musk dominated late-night monologues. Tonight though, it wasn’t a black-eyed Musk ...